HOME >> BIOLOGY >> NEWS
Honey in the medicine cabinet!

Honey researchers to discuss honey's role in medicine and functional foods

Beekeepers, scientists, honey packers and marketing representatives will meet to discuss the future of the beekeeping industry at Apimondia '99, an International Apicultural Congress to be held in Vancouver, BC, September 12 through 18, 1999. This year's theme is "Beekeeping in the New Millennium," and of particular importance is the research into honey's promise for use in medicine, and as a functional food ingredient.

On Tuesday, September 13, Dr. Peter C. Molan, Associate Professor of Biochemistry at the University of Waikato, New Zealand will be the keynote speaker at a plenary session entitled "The Scientific Basis of Apitherapy." In his presentation "Establishing Honey as a Recognized Medicine," Dr. Molan will present the latest research results of the effectiveness of honey against the antibiotic-resistant strains of bacteria that pose a real problem for infection control in hospitals. These so-called "super bugs" are as sensitive as the normal strains to the antibacterial activity of honey.

Numerous clinical trials have demonstrated that honey dressings rapidly clear bacteria from infected wounds. A clinical trial has also demonstrated that simply dressing with honey is just as effective as aggressive surgical removal of infected tissue as a treatment for necrotising fasciitis, the "flesh-eating" bacteria. Dr. Molan will also present research results showing the effectiveness of honey in killing the streptococci that cause that infection.

Dr. Molan heads The University of Waikato Honey Research Unit which is recognized for its expertise in the composition of honey and its antimicrobial activity.

The Honey Research Unit is involved in research on a wide variety of topics such as:

  • Assessment of methods of the effectiveness of the
    '"/>


Contact: Mary Ann Johnson
mjohnson@zfpartners.com
415-268-5421
Zuckerman Fernandes & Partners
26-Aug-1999


Page: 1 2

Related biology news :

1. Honey bee genome assembled
2. Honeybee gene find ends 150-year search
3. Honey bee genome being sequenced
4. Honey the darker the better Has potential as dietary antioxidant
5. USDA establishes Honeybee Genetics and IPM Center
6. Honey shines in athletic research, has scientific community abuzz
7. Honey as healer
8. Honey : Naturess sweetener may increase recuperation after workouts
9. Honey may be the ideal pre-workout energy source
10. Dark Honey Has More Illness-Fighting Agents Than Light Honey
11. Summer Science: Where Have All The Honeybees Gone? UD Bee Guy Asks Why--From America To The Amazon

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Honey the medicine cabinet

(Date:8/26/2015)... , August 26, 2015 ... Four, and Five Factor), Application (Travel & Immigration, Government, ... - Global Forecast to 2020", published by MarketsandMarkets, Multi-Factor ... by 2020, growing at a CAGR of 17.7% between ... and 82 F igures spread through 169 ...
(Date:8/20/2015)... Aug. 20, 2015   Sensory, Inc ., ... the user experience and security of consumer electronics ... announced that its TrulySecure™ is the ... to be FIDO Certified™. The FIDO ... with the FIDO UAF (Universal Authentication Framework) 1.0 ...
(Date:8/17/2015)... Aug. 17, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... campaign for Q4 2015. The new marketing campaign is ... of Amplitude Marketing Group ( http://amplitudemarketing.com/ ) and TPMG ... a leader in retail driven marketing and brand awareness ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3
(Date:9/2/2015)... 2, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Nanobiotechnology ... offering. An increasing use ... industries is anticipated. Nanotechnology will be applied ... from formulations for optimal delivery to diagnostic ...
(Date:9/2/2015)... 02, 2015 Research ... addition of Jain PharmaBiotech,s new report "Biomarkers ... offering. This report follows the broad ... can be objectively measured and evaluated as an ... well as pharmacological responses to a therapeutic intervention. ...
(Date:9/2/2015)...  Neurotech Pharmaceuticals, Inc., announced today the first ... 2 clinical trial of NT-503 Encapsulated Cell Therapy ... choroidal neovascularization secondary to age related macular degeneration ... growth factor (VEGF) receptor protein continuously produced by ... proof-of-concept study will evaluate NT-503 ECT as a ...
(Date:9/2/2015)... , September 2, 2015 BiondVax ... of the National Institute of Allergy and Infectious Diseases (NIAID), ... the Department of Health and Human Services (HHS), to launch ... the United States in the 2015-16 timeframe. ... vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which would ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
Cached News: